Bessemer Group Inc. Has $2.85 Million Position in Masimo Corporation (NASDAQ:MASI)

Bessemer Group Inc. lowered its position in Masimo Corporation (NASDAQ:MASI) by 0.0% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 31,291 shares of the medical equipment provider’s stock after selling 9 shares during the period. Bessemer Group Inc. owned about 0.06% of Masimo Corporation worth $2,853,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in MASI. Teachers Advisors LLC boosted its position in Masimo Corporation by 343.5% in the fourth quarter. Teachers Advisors LLC now owns 304,589 shares of the medical equipment provider’s stock worth $20,529,000 after buying an additional 235,903 shares in the last quarter. Koshinski Asset Management Inc. purchased a new position in Masimo Corporation during the first quarter worth approximately $207,000. Legato Capital Management LLC boosted its position in Masimo Corporation by 6,238.2% in the first quarter. Legato Capital Management LLC now owns 115,736 shares of the medical equipment provider’s stock worth $1,241,000 after buying an additional 113,910 shares in the last quarter. Retirement Systems of Alabama purchased a new position in Masimo Corporation during the first quarter worth approximately $5,403,000. Finally, Nationwide Fund Advisors boosted its position in Masimo Corporation by 25.8% in the first quarter. Nationwide Fund Advisors now owns 324,526 shares of the medical equipment provider’s stock worth $30,265,000 after buying an additional 66,524 shares in the last quarter. 84.14% of the stock is owned by hedge funds and other institutional investors.

Masimo Corporation (NASDAQ:MASI) traded down 1.68% during midday trading on Friday, hitting $85.78. 497,663 shares of the stock traded hands. The firm has a market cap of $4.46 billion, a P/E ratio of 14.06 and a beta of 0.80. The company’s 50-day moving average is $91.26 and its 200 day moving average is $90.35. Masimo Corporation has a 12-month low of $53.78 and a 12-month high of $104.71.

Masimo Corporation (NASDAQ:MASI) last posted its quarterly earnings data on Wednesday, August 2nd. The medical equipment provider reported $0.83 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.71 by $0.12. Masimo Corporation had a net margin of 45.90% and a return on equity of 23.45%. The business had revenue of $192.90 million during the quarter, compared to analyst estimates of $189.03 million. During the same quarter last year, the firm posted $0.57 earnings per share. The business’s revenue for the quarter was up 11.8% compared to the same quarter last year. On average, analysts anticipate that Masimo Corporation will post $2.80 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: “Bessemer Group Inc. Has $2.85 Million Position in Masimo Corporation (NASDAQ:MASI)” was originally reported by Community Financial News and is owned by of Community Financial News. If you are viewing this article on another publication, it was stolen and republished in violation of US and international trademark and copyright laws. The correct version of this article can be viewed at https://www.com-unik.info/2017/08/19/masimo-corporation-nasdaqmasi-shares-sold-by-bessemer-group-inc-updated.html.

MASI has been the subject of a number of recent analyst reports. Zacks Investment Research cut shares of Masimo Corporation from a “strong-buy” rating to a “hold” rating in a research note on Thursday, May 11th. Wedbush reaffirmed an “outperform” rating and set a $112.00 price target on shares of Masimo Corporation in a research note on Monday, May 22nd. BidaskClub lowered shares of Masimo Corporation from a “buy” rating to a “hold” rating in a report on Wednesday, July 5th. Stifel Nicolaus assumed coverage on shares of Masimo Corporation in a report on Monday, July 10th. They set a “buy” rating and a $105.00 price objective for the company. Finally, Roth Capital lifted their price objective on shares of Masimo Corporation from $96.00 to $105.00 and gave the company a “buy” rating in a report on Wednesday, July 19th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and four have issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average price target of $95.00.

In other news, insider Rick Fishel sold 15,000 shares of the firm’s stock in a transaction that occurred on Tuesday, July 11th. The shares were sold at an average price of $92.85, for a total value of $1,392,750.00. Following the completion of the transaction, the insider now owns 35,022 shares of the company’s stock, valued at $3,251,792.70. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Sanford Fitch sold 14,000 shares of the firm’s stock in a transaction that occurred on Thursday, June 29th. The shares were sold at an average price of $92.06, for a total transaction of $1,288,840.00. Following the completion of the transaction, the director now directly owns 90,249 shares of the company’s stock, valued at approximately $8,308,322.94. The disclosure for this sale can be found here. In the last three months, insiders sold 115,000 shares of company stock valued at $10,773,180. Insiders own 16.60% of the company’s stock.

About Masimo Corporation

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Institutional Ownership by Quarter for Masimo Corporation (NASDAQ:MASI)

What are top analysts saying about Masimo Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Masimo Corporation and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit